Ting Capital News Today

/PRNewswire/ -- Rona Therapeutics, a fully integrated platform company dedicated to the discovery, development and manufacturing of RNA therapeutics announces...

Regor Therapeutics Announces Completion of $90 Million Series B Financing News provided by Share this article Share this article SHANGHAI, Feb. 18, 2021 /PRNewswire/ -- Regor Therapeutics, a clinical stage biotechnology company dedicated to the discovery of innovative medicines to treat cancer, immune disorders and metabolic diseases, announces the successful completion of $90 million Series B financing. Founded in July of 2018 by a group of veteran drug hunters with extensive research and exec...